Demand for potassium sorbate is on track to experience a steady rise, with its industry value estimated to reach USD 69.8 million by 2025. The total industry size is anticipated to grow at a CAGR of 6.9% from 2025 to 2035, ultimately reaching USD 136.1 million by the end of the forecast period. This surge is largely attributed to the compound’s extensive use across multiple industries, including food and beverages, cosmetics, and pharmaceuticals.

Potassium sorbate’s popularity stems from its role as a safe and effective preservative, inhibiting the growth of molds, yeasts, and bacteria. With consumer preferences shifting toward products with longer shelf lives, especially in packaged and processed foods, the market is witnessing consistent growth. Increased demand from the pharmaceutical and personal care sectors is also contributing to expansion, particularly as brands seek clean-label preservatives with proven safety profiles.

Your Guide to Market Intelligence – Download a Sample Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-17828

Growing Awareness of Food Safety Spurs Potassium Sorbate Market Expansion

The global potassium sorbate market is witnessing significant growth, with projections indicating strong momentum between 2025 and 2035. As consumers become increasingly health-conscious, the demand for non-toxic antimicrobial agents and clean label preservatives in food processing is on the rise. Potassium sorbate, a sorbic acid salt, continues to gain traction as a safe and effective preservative across the food and beverage industry.

Potassium sorbate’s ability to extend the shelf life of products without altering taste, odor, or appearance makes it indispensable in modern food manufacturing. The compound is widely used in bakery and dairy products, beverages, confectionery, and personal care items. This trend aligns with the broader consumer shift towards transparency and sustainability in food ingredients.

Rising Demand in Food and Beverage Sector

The food and beverage industry remains the largest application segment for potassium sorbate. With the continued expansion of the packaged and convenience foods market, the use of preservatives that ensure long-lasting freshness has become a necessity. Potassium sorbate’s efficacy in controlling mold, yeast, and fungal growth allows manufacturers to reduce food spoilage and meet the growing demand for natural vs synthetic food additives.

Additionally, potassium sorbate’s GRAS (Generally Recognized As Safe) status by key regulatory agencies ensures its broad usage in industrial applications of potassium sorbate by region, particularly in food safety-compliant nations.

Personal Care and Pharmaceutical Applications Gaining Momentum

Beyond food and beverage, potassium sorbate is increasingly used in personal care and cosmetic formulations. It helps stabilize products such as lotions, creams, and shampoos by preventing microbial growth. In the pharmaceutical sector, potassium sorbate acts as a preservative in oral medications and topical solutions, further supporting its versatile market potential.

The demand for shelf-life enhancement ingredients in these sectors underscores the importance of potassium sorbate as a cost-effective and safe option for long-term product integrity.

Access All the Insights You Need – Download Full Report Now: https://www.futuremarketinsights.com/reports/potassium-sorbate-market

Competitive Analysis

The potassium sorbate market is moderately consolidated, with key players focusing on product innovation, capacity expansion, and regional penetration. Some of the leading companies include:

• Celanese Corporation

• Tengzhou Aolong Fine Chemical Co., Ltd.

• FBC Industries

• Spectrum Chemical Mfg. Corp.

• Shandong Tong Tai Wei Run Chemical Co., Ltd.

Strategic partnerships, long-term supply agreements, and compliance with international food safety regulations are central to maintaining competitive advantage.

Market Country-wise Analysis (2025–2035)

• United States: The market in the U.S. is projected to grow at a CAGR of 4.5%, driven by strong demand in food and beverage manufacturing and clean-label product trends.

• United Kingdom: Expected to grow at 4.2%, fueled by innovation in organic food products and stricter food safety regulations.

• France: Forecasted CAGR of 3.8%, with increased use in cosmetics and bakery applications.

• Germany: At 4%, Germany continues to be a strong player due to advanced food processing industries.

• Italy: The market is set to expand at 3.9%, supported by consumer demand for artisanal and shelf-stable food products.

• South Korea: Growing at 4.3%, the demand is rising in skincare and pharmaceutical segments.

• Japan: CAGR stands at 3.7%, with steady usage across processed food and traditional snacks.

• China: Leading growth at 5.1%, China is seeing rapid expansion due to urbanization and increased packaged food consumption.

• Australia: Expected growth of 4.1%, backed by rising health consciousness and demand for natural preservatives.

• New Zealand: With a CAGR of 3.6%, growth is slower but steady, driven by niche organic food markets.

Explore Functional Food Ingredients Industry Analysis: https://www.futuremarketinsights.com/industry-analysis/functional-food-ingredients

Potassium Sorbate Market by Form, Application, Purity, Function, and Region

By Product Type:

By product type, the industry is classified as powder, granular, and liquid.

By Application:

By application, the industry is classified as food and beverages, animal feed, pharmaceuticals, and personal care.

By Region:

By region, the industry divided as North America, Latin America, Europe, East Asia, South Asia, Oceania, and The Middle East & Africa.

Dr Kathy Trieu (PhD) hopes seven million Australians with high blood pressure will make the switch over the next two years.

Dr Kathy Trieu.

There is too much sodium in our diets and not enough potassium — an obvious problem to anyone who learnt about the sodium-potassium pump in biology class.

This is why Dr Kathy Trieu (PhD), a nutrition expert at the George Institute for Global Health, is leading a campaign to shift to potassium-enriched salt.

Have Kidney Trouble? These Popular Health Foods May Be Doing More Harm Than Good

Curated By :

News18.com

Last Updated: June 23, 2025, 13:50 IST

If you are struggling from any kidney related ailment, the food items which are known for their health benefits may be harmful for you.

Advertisement

The kidneys are among the body’s most hardworking organs, quietly managing more than 2,000 vital functions – from filtering toxins to balancing essential minerals like sodium, potassium, and phosphorus. But when kidney function begins to decline, even foods touted as “healthy” can pose unexpected risks. Surprisingly, some nutrient-rich staples may strain the kidneys, disrupt electrolyte balance, or contribute to further damage.

Kidney patients should avoid high potassium foods like bananas and avocados. (AI Generated Image)

Understanding which nutrients become problematic is crucial for kidney disease management. Dr. Anoop M Gowda, Consultant Nephrologist & Transplant Physician, Apollo Hospitals, Seshadripuram, explains, “For instance, sodium directly increases blood pressure and accelerates kidney deterioration, leading to increased risk of heart attack and stroke. Potassium, which can only be processed by the kidneys, becomes particularly dangerous when kidney function falls below 30% – excess potassium causes serious heart rhythm problems that can be life-threatening.”

Recommended Stories

“Meanwhile, phosphorus, a byproduct of protein metabolism, accumulates in failing kidneys and combines with calcium to harden blood vessels, creating a cascade of cardiovascular complications, including dangerous blood pressure spikes,” adds Dr Gowda

When kidneys fail, they lose their ability to properly filter and regulate the vital nutrients, leading to dangerous accumulations that can cause heart problems, bone disease, and rapid deterioration of remaining kidney function. Dr Gowda shares a list of ten foods that may do more harm than good if your kidneys are compromised.

Bananas – These potassium powerhouses are often recommended for heart health, but a single banana contains about 420 mg of potassium, potentially dangerous for those with kidney disease stages 3-5.

Spinach and Dark Leafy Greens – Packed with vitamins but also loaded with potassium (840 mg per cup of cooked spinach) and oxalates that can worsen kidney stone formation.

Avocados – Despite their healthy fats, one medium avocado contains nearly 1,000mg of potassium, more than twice the amount in a banana.

Nuts and Seeds – Almonds, pistachios, and sunflower seeds are nutritional powerhouses but extremely high in phosphorus and potassium, making them risky for kidney patients.

Whole Grain Breads and Cereals – The phosphorus additives in processed whole grains are particularly problematic, as they’re more easily absorbed than natural phosphorus.

Low-Sodium Salt Substitutes – Ironically, these products replace sodium with potassium chloride, creating a dangerous potassium overload for kidney patients.

Orange Juice and Citrus Fruits – One cup of orange juice contains 470 mg of potassium, and the high vitamin C content can increase oxalate production.

Tomatoes and Tomato Products – Fresh tomatoes, sauce, and paste are concentrated sources of potassium, with tomato paste containing over 650 mg per quarter cup.

Greek Yoghurt – While praised for protein content, Greek yoghurt is significantly higher in phosphorus and potassium than regular yoghurt.

Dark Chocolate – This tasty treat contains high levels of both potassium (200mg per ounce) and phosphorus, making it a double threat for kidney patients.

top videos View all Swipe Left For Next Video View all

Dr Gowda explains, “If you have a kidney disease, what’s ‘healthy’ for the general population may not be healthy for you. These foods aren’t inherently bad. They’re problematic specifically when kidneys can’t properly process their nutrients.”

Before making any dietary changes, it’s essential to consult a nephrologist or a registered dietitian who specialises in kidney health. With the right guidance, managing your diet can play a powerful role in slowing the progression of kidney disease.

fashion, travel, The News18 Lifestyle section brings you the latest on health food , and culture — with wellness tips, celebrity style, travel inspiration, and recipes. Also Download the News18 App to stay updated!

Location : Delhi, India, India

First Published: June 23, 2025, 13:50 IST

With global hypertension and diabetes on the rise, researchers are investigating whether switching to potassium- or magnesium-based salts can help manage blood pressure without sacrificing taste or adherence.

Study: Sodium salt substitution for blood pressure in adults with diabetes. Image Credit: luchschenF / Shutterstock

In a recent research protocol published in the Cochrane Database of Systematic Reviews, researchers described their methods to systematically evaluate whether replacing regular sodium salt with substitutes such as potassium chloride, magnesium chloride, or other edible salts can reduce blood pressure in people with diabetes mellitus.

Their analysis will focus on changes in systolic, diastolic, and mean arterial blood pressure as the outcomes of interest, aiming to clarify both the benefits and harms of replacing common salt in the diet for people with this condition.

Dual burden of diabetes and hypertension

Hypertension (high blood pressure) is one of the leading causes of global illness and death, contributing significantly to cardiovascular diseases like heart attacks, strokes, and heart failure.

The World Health Organization estimates that by 2025, around 1.6 billion people worldwide will be living with hypertension, with a large proportion in low- and middle-income countries.

Diabetes mellitus, another major public health challenge, often coexists with hypertension. In people with diabetes, physiological changes such as increased fluid volume and vascular resistance make them particularly prone to high blood pressure, which further raises their risk for severe cardiovascular complications.

Potential for substituting table salt

Reducing dietary salt intake is a widely recommended and tested lifestyle strategy for controlling blood pressure. However, people vary in how strongly their blood pressure responds to sodium reduction, and adherence to a low-sodium diet can be challenging.

Besides simply cutting salt, substituting regular table salt (sodium chloride) with salts richer in potassium or magnesium has shown promise in lowering blood pressure in the general population.

Magnesium and potassium play important roles in regulating vascular tone and fluid balance. Evidence suggests that people with diabetes often have lower levels of these minerals, which may worsen blood pressure control.

Salt substitutes that combine reduced sodium with increased potassium and magnesium may offer a practical way to lower blood pressure without requiring drastic changes in diet or taste.

Substitutes have shown good consumer acceptance in taste trials, including national studies such as the Dutch Food Survey and a triangle test in Peru. For people with diabetes, who struggle with both high blood pressure and low potassium or magnesium levels, salt substitution could be a particularly useful intervention.

Despite existing guidelines such as those from the American Diabetes Association recommending reduced sodium and increased potassium intake via dietary approaches like DASH, there is a lack of clear, high-quality evidence specifically focused on salt substitution in diabetic populations.

Study objectives and methods

This review aims to assess whether substituting regular sodium salt with other edible salts, such as potassium chloride or magnesium chloride, effectively lowers blood pressure in adults with type 1 or type 2 diabetes mellitus. The primary focus is on measuring changes in systolic and diastolic blood pressure using standardized methods.

To achieve this, the review will follow Cochrane’s guidelines and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 reporting standards. It will include randomized controlled trials (RCTs) and quasi-randomized controlled trials (quasi-RCTs) that compare a diet with substitutes to regular sodium with a regular sodium salt diet, a sodium-restricted diet, or no intervention. Eligible studies must measure salt intake using 24-hour urinary excretion.

Participants will be adults with type 1 or type 2 diabetes, excluding pregnant women to ensure the review focuses solely on type 1 and type 2 diabetes mellitus. Studies with other comorbidities can be included if data for the diabetic subgroup are available. Trials must last at least one week.

Primary outcomes include changes in mean, diastolic, and systolic blood pressure. Secondary outcomes will cover withdrawals, adverse effects, changes in blood and urinary markers (glucose, creatinine, albumin, magnesium, potassium, and sodium), treatment adherence, and quality of life. The review will include both narrative and quantitative syntheses where appropriate data are available.

Systematic review process

This systematic review will comprehensively identify and analyze studies evaluating the effects of salt substitution on blood pressure in individuals with diabetes. An experienced Information Specialist will search major electronic databases without restrictions on language or publication status.

Bibliographies of relevant studies and systematic reviews will also be screened, and retraction checks will be performed via established retraction sources. Two authors will independently screen abstracts, titles, and full texts, extract data using standard templates, and assess the risk of bias using Cochrane’s RoB 1 tool.

Extracted data will include participant demographics, intervention details, study design, and outcomes, such as quality of life, biochemical markers, urinary excretion levels, changes in blood pressure, and adverse events.

For analysis, treatment effects will be measured as mean differences or risk ratios with 95% confidence intervals, applying a random-effects meta-analysis if studies are sufficiently homogeneous.

Subgroup and sensitivity analyses will explore factors such as the type of salt substitute, trial duration, comparator, type of diabetes, and the use of other interventions. The certainty of evidence will be assessed using the GRADE approach, considering study limitations, inconsistency, indirectness, imprecision, and publication bias.

The protocol notes that health equity will not be assessed as part of this review.

Brenda Agüero, a 30-year-old nurse in Córdoba province, received a life sentence for the murder of five newborn babies and the attempted killing of eight others between March and June 2022. The events, which caused a commotion in the province, bear striking similarities with the case of Lucy Letby, a nurse in the U.K. serving 15 life sentences for seven baby deaths at neonatal units between 2015 and 2016.

On Thursday, the jury agreed with the prosecution’s case, which stated that Agüero had injected at least thirteen babies with insulin and potassium when she worked in the Córdoba Neonatal Hospital. Five of those babies died as a result of the injections, and eight survived, albeit some of them with permanent consequences.

“One has irreversible neurological damage due to the administration of insulin, and another, due to an injection of potassium in her back, which ate all the muscle, leaving them with irreversible severe scoliosis,” Daniela Morales Leanza, attorney for the families of six babies, told the Herald.

Five of the hospital’s authorities were also found guilty of charges ranging from omission of duties of a public official to cover-up, with five-year prison sentences.

“I am not that monster that they have created in the media. I understand the pain of the mothers, but I am not the serial killer that they made everyone believe,” said Agüero in her last words of the trial.

The mothers of the victims listened to the verdict in the court, wearing T-shirts with pictures of their children. Families also adorned the courthouse gates with photos of the deceased and affected babies and balloons. A banner reading “Justice for the babies of the Neonatal” could be seen in the courtroom.

A long road to justice

“It was a mixture of emotions and anxiety because the day of the verdict was a very long hearing, but it was what we were waiting for,” Morales Leanza said.

The nurse will serve her sentence in the Bouwer Penitentiary Complex in Córdoba, where she had already been housed for the past three years.

“We understood that, in the 13 facts, the participation and responsibility of Brenda Aguero have been proved with absolute certainty, without any kind of doubt.”

The evidence included time sheets and patient medical records confirming Agüero’s presence in the ward in question during the times of the incidents. Other facts included were testimonies of mothers who recognized her, the fact that she was the only nurse whose presence was noted in all 13 incidents, and that her cell phone contained numerous photographs of the medical records of the babies who became ill.

Psychological and psychiatric evaluations of Agüero showed she displayed narcissistic and eccentric traits, as well as a lack of empathy and even satisfaction in the suffering of others.

According to court testimony and evidence, Agüero’s motivation stemmed from a desire for recognition and a need to be the center of attention.

“She was playing god. She decided who lived and who died,” said the attorney.

Furthermore, her actions were driven by an ambition to advance her career in neonatology, Morales Leanza said, as she often detected the babies’ decompensations before they took place and was often congratulated for that.

“There is a testimony of a mother who identified her … [Agüero] took the baby out of her arms, turned around, went to the side, and put [something] in the baby’s body. The baby immediately screamed as if she had been pinched,” said the lawyer. “This testimony was given by the mother before Brenda’s name came out and before anyone was detained.”

The defense’s stance

Agüero’s lawyer, Gustavo Nievas, told the Herald that the nurse was a scapegoat for systemic issues within the hospital. He said that the babies most likely died from a “generalized sepsis” due to the hospital’s collapse. According to Nievas, the Neonatal Hospital had a spike in its attendance, as it was performing a high number of abortions that other medical centers from more conservative parts of the province refused to do.

According to Nievas, the hospital’s authorities cleaned the facility to erase evidence, but in turn, they decontaminated the place. According to the lawyer, that would be the reason why the deaths and decompensations stopped.

“The crime scene disappeared,” he said.

For Morales Leanza, Nievas’ argument doesn’t hold up. She said that experts explained that the decreased newborns’ had blood insulin levels so high that they are not even seen in adults with advanced pancreatic cancer.

“That means somebody administered [insulin] either intentionally or by accident. If the claim is that it was by accident, how are you going to administer insulin to a healthy newborn? There is no medical indication to do so.”

“We’re talking about a baby with three or four pricks in their legs, with unexplained potassium levels,” she added.

The attorney said that, after the first two deaths, hospital authorities requested a change of a vitamin K lot, believing it caused the deaths. They also searched for needles in mattresses. However, they failed to report these incidents as potential crimes to the authorities. They even held a meeting with a prosecutor to discuss the situation, but no formal report was filed.

But then, June 6th happened. “It was a fateful night where there were four episodes — two deaths, two babies with insulinemia of 1000, another one with a prick in the back,” said the lawyer. “The next day, there was chaos in the hospital. Such a thing had never happened.”

That is why the lawyer protested the jury’s decision of absolving then-health minister Diego Cardozo, who failed to file a complaint before that day. She told the Herald she is discussing with the mothers how to proceed and will make a decision after July 23, when the verdict’s foundations will be made public.